Affinity Appoints David Katterhenrich as Vice President of Medical Marketing
Added: (Mon Jan 19 2004)
Pressbox (Press Release) -
OVERLAND PARK, Ks., Nov. 13, 2003 – Affinity Medical Communications today announced that David J. Katterhenrich has assumed the role of Vice President of Medical Marketing. Mr. Katterhenrich will be responsible for developing innovative marketing programs for pharmaceutical and medical education products.
“We are excited about working with Dave,” said Faruk Capan, founder and Chief Executive Officer of Affinity. “Dave has been a prominent figure in the pharmaceutical industry and CME community. He’s been able to channel his experience into powerful e-detailing and eCME solutions for our clients. We are looking forward to Dave’s valuable contributions to the company.”
Mr. Katterhenrich brings more than two decades of experience in the pharmaceutical industry, with positions at Aventis and its predecessor companies, beginning with Marion Laboratories. Most recently, Mr. Katterhenrich was Vice President of the Science and Education Division of Pharmion Corporation, a global specialty pharmaceutical company in oncology and hematology. He has also held leadership roles in Scientific Communications and was active among industry representatives in the CME community.
Affinity Medical Communications combines medical marketing expertise, quality content, and revolutionary technology to create industry-leading resources. The company takes a relationship-driven approach to communications, forming strategic partnerships with clients and creating unique solutions. Affinity’s core products include physician e-detailing, online continuing medical education, patient education and patient adherence/compliance programs. All Affinity programs comply with industry regulations and guidelines.
Affinity boasts more than three decades of experience in medical marketing, medical education and information technology and an information network that extends to physician and association thought leaders across many therapeutic areas including neurology, allergy and asthma, oncology, hematology, cardiology, gastroenterology, rheumatology, metabolic disease, infectious disease, osteoporosis, addiction medicine, and clinical pharmacy.
More information about Affinity’s products, philosophy, and professional team can be found at www.AffinityMedCom.com, or by contacting Robyn Duzenberry at (913) 345-2100.
Phone: (913) 345-2100
Fax: (913) 345-9599
Affinity Medical Communications
Corporate Woods Building 12
10975 Benson, Suite 350
Overland Park, KS 66210